{"id":"https://openalex.org/W2095004792","doi":"https://doi.org/10.1007/s12350-012-9547-4","title":"A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease","display_name":"A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease","alternate_titles":[],"publication_year":2012,"publication_date":"2012-04-06","ids":{"openalex":"https://openalex.org/W2095004792","doi":"https://doi.org/10.1007/s12350-012-9547-4","mag":"2095004792","pmid":"https://pubmed.ncbi.nlm.nih.gov/22484721","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3395344"},"language":"en","primary_location":{"id":"doi:10.1007/s12350-012-9547-4","doi":"https://doi.org/10.1007/s12350-012-9547-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12350-012-9547-4","pdf_url":"https://www.journalofnuclearcardiology.org/article/S1071-3581(23)03142-2/pdf","source":{"id":"https://openalex.org/S40505786","display_name":"Journal of Nuclear Cardiology","issn_l":"1071-3581","issn":["1071-3581","1532-6551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nuclear Cardiology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2095004792"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.journalofnuclearcardiology.org/article/S1071-3581(23)03142-2/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005080145","display_name":"Bruce M. Prenner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Bruce M. Prenner","raw_affiliation_strings":["Allergy Associates Medical Group, Inc, San Diego, CA 92120, USA. prenner@aaamg.com","Allergy Associates Medical Group, Inc., San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergy Associates Medical Group, Inc, San Diego, CA 92120, USA. prenner@aaamg.com","institution_ids":[]},{"raw_affiliation_string":"Allergy Associates Medical Group, Inc., San Diego, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072518496","display_name":"Stan Bukofzer","orcid":"https://orcid.org/0009-0007-5545-8210","observed_orcids":["https://orcid.org/0009-0007-5545-8210"]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stan Bukofzer","raw_affiliation_strings":["Astellas Pharma Global Development, Inc., 3 Parkway North, Deerfield, IL, USA","Astellas Pharma Global Development Inc., Deerfield, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Pharma Global Development, Inc., 3 Parkway North, Deerfield, IL, USA","institution_ids":["https://openalex.org/I4210165171"]},{"raw_affiliation_string":"Astellas Pharma Global Development Inc., Deerfield, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032021851","display_name":"Sarah Behm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Behm","raw_affiliation_strings":["Astellas Pharma Global Development, Inc., 3 Parkway North, Deerfield, IL, USA","Astellas Pharma Global Development Inc., Deerfield, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Pharma Global Development, Inc., 3 Parkway North, Deerfield, IL, USA","institution_ids":["https://openalex.org/I4210165171"]},{"raw_affiliation_string":"Astellas Pharma Global Development Inc., Deerfield, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035529881","display_name":"Kathleen Feaheny","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen Feaheny","raw_affiliation_strings":["Astellas Pharma Global Development, Inc., 3 Parkway North, Deerfield, IL, USA","Astellas Pharma Global Development Inc., Deerfield, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Pharma Global Development, Inc., 3 Parkway North, Deerfield, IL, USA","institution_ids":["https://openalex.org/I4210165171"]},{"raw_affiliation_string":"Astellas Pharma Global Development Inc., Deerfield, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042693977","display_name":"Bruce E. McNutt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce E. McNutt","raw_affiliation_strings":["Astellas Pharma Global Development, Inc., 3 Parkway North, Deerfield, IL, USA","Astellas Pharma Global Development Inc., Deerfield, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Pharma Global Development, Inc., 3 Parkway North, Deerfield, IL, USA","institution_ids":["https://openalex.org/I4210165171"]},{"raw_affiliation_string":"Astellas Pharma Global Development Inc., Deerfield, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5005080145"],"corresponding_institution_ids":[],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":{"value":4190,"currency":"USD","value_usd":4190},"fwci":6.461,"has_fulltext":true,"cited_by_count":86,"citation_normalized_percentile":{"value":0.98294328,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"19","issue":"4","first_page":"681","last_page":"692"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.5468999743461609,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.5468999743461609,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10372","display_name":"Cardiac Imaging and Diagnostics","score":0.37869998812675476,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.01720000058412552,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/regadenoson","display_name":"regadenoson","score":1.0},{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.9259999990463257},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":1.0},{"id":"https://openalex.org/keywords/adenosine-receptor-agonists","display_name":"adenosine receptor agonists","score":0.7990000247955322},{"id":"https://openalex.org/keywords/bronchoconstriction","display_name":"bronchoconstriction","score":0.8339999914169312},{"id":"https://openalex.org/keywords/myocardial-perfusion-imaging","display_name":"myocardial perfusion imaging","score":0.8690000176429749},{"id":"https://openalex.org/keywords/dyspnea","display_name":"dyspnea","score":0.7360000014305115},{"id":"https://openalex.org/keywords/fev1","display_name":"FEV1","score":0.6869999766349792},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8299999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9500224590301514},{"id":"https://openalex.org/C2777361974","wikidata":"https://www.wikidata.org/wiki/Q7307897","display_name":"Regadenoson","level":4,"score":0.9276902675628662},{"id":"https://openalex.org/C2780769369","wikidata":"https://www.wikidata.org/wiki/Q4375","display_name":"Bronchoconstriction","level":3,"score":0.7515707015991211},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.747212290763855},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.7316205501556396},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7132997512817383},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5796590447425842},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5295316576957703},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.44182753562927246},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.41969233751296997},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3826793134212494},{"id":"https://openalex.org/C2778405248","wikidata":"https://www.wikidata.org/wiki/Q1956679","display_name":"Myocardial perfusion imaging","level":3,"score":0.37423354387283325},{"id":"https://openalex.org/C146957229","wikidata":"https://www.wikidata.org/wiki/Q1266915","display_name":"Perfusion","level":2,"score":0.11404529213905334},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0636281669139862},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005541","descriptor_name":"Forced Expiratory Volume","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055414","descriptor_name":"Myocardial Perfusion Imaging","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D058906","descriptor_name":"Purinergic P1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058917","descriptor_name":"Adenosine A2 Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s12350-012-9547-4","doi":"https://doi.org/10.1007/s12350-012-9547-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12350-012-9547-4","pdf_url":"https://www.journalofnuclearcardiology.org/article/S1071-3581(23)03142-2/pdf","source":{"id":"https://openalex.org/S40505786","display_name":"Journal of Nuclear Cardiology","issn_l":"1071-3581","issn":["1071-3581","1532-6551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nuclear Cardiology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2535163","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3395344","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:22484721","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22484721","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology","raw_type":"Clinical Trial, Phase IV"},{"id":"pmh:oai:pubmedcentral.nih.gov:3395344","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3395344/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Nucl Cardiol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s12350-012-9547-4","doi":"https://doi.org/10.1007/s12350-012-9547-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12350-012-9547-4","pdf_url":"https://www.journalofnuclearcardiology.org/article/S1071-3581(23)03142-2/pdf","source":{"id":"https://openalex.org/S40505786","display_name":"Journal of Nuclear Cardiology","issn_l":"1071-3581","issn":["1071-3581","1532-6551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nuclear Cardiology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320310400","display_name":"Dartmouth College","ror":"https://ror.org/049s0rh22"},{"id":"https://openalex.org/F4320311407","display_name":"Sunovion","ror":"https://ror.org/030zc7t66"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332563","display_name":"Astellas Pharma Global Development","ror":"https://ror.org/05pw69n24"},{"id":"https://openalex.org/F4320332585","display_name":"Allergan","ror":"https://ror.org/00wthd003"},{"id":"https://openalex.org/F4320337356","display_name":"Fogarty International Center","ror":"https://ror.org/02xey9a22"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2095004792.pdf","grobid_xml":"https://content.openalex.org/works/W2095004792.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1569222873","https://openalex.org/W1916479001","https://openalex.org/W1984550508","https://openalex.org/W1995593937","https://openalex.org/W2022472954","https://openalex.org/W2030766747","https://openalex.org/W2035955996","https://openalex.org/W2043884149","https://openalex.org/W2060976026","https://openalex.org/W2064930451","https://openalex.org/W2114023904","https://openalex.org/W2136607333","https://openalex.org/W2146960414","https://openalex.org/W2336431486","https://openalex.org/W4230473488"],"related_works":["https://openalex.org/W2030766747","https://openalex.org/W2035955996","https://openalex.org/W2136470658","https://openalex.org/W2889195100","https://openalex.org/W2104274928","https://openalex.org/W2479038479","https://openalex.org/W3106722033","https://openalex.org/W2384735680","https://openalex.org/W1989171326","https://openalex.org/W1964678155"],"abstract_inverted_index":{"BACKGROUND:":[0],"Adenosine":[1],"receptor":[2,47,170],"stress":[3,192],"agents":[4],"for":[5,63,194],"myocardial":[6],"perfusion":[7],"imaging":[8],"(MPI)":[9],"may":[10,184],"cause":[11],"A(2B)":[12],"and/or":[13],"A(3)":[14],"receptor-mediated":[15],"bronchoconstriction,":[16,161],"of":[17,43,87,165],"particular":[18],"concern":[19],"to":[20,97,101,187],"physicians":[21,188],"testing":[22],"patients":[23,197],"with":[24,51,55,71,78,131,168,198],"asthma":[25,56,72,119,147,199],"or":[26,57,120,200],"chronic":[27],"obstructive":[28],"pulmonary":[29],"disease":[30],"(COPD).":[31],"METHODS:":[32],"A":[33],"Phase":[34],"4,":[35],"randomized,":[36],"double-blind":[37],"study":[38],"(NCT00862641)":[39],"assessed":[40],"the":[41,44,111,114,118,124,138,142,146,163],"safety":[42],"selective":[45],"A(2A)":[46],"agonist,":[48],"regadenoson,":[49],"compared":[50],"placebo":[52,115,143],"in":[53,93,117,137,145,196],"subjects":[54,70,77,88,158],"COPD":[58,79,121,152],"who":[59],"represented":[60],"likely":[61],"candidates":[62],"MPI.":[64],"RESULTS:":[65],"Overall,":[66],"356":[67],"and":[68,73,75,82,113,151],"176":[69],"316":[74],"151":[76],"received":[80],"regadenoson":[81,112,139],"placebo,":[83],"respectively.":[84],"The":[85],"percentage":[86],"experiencing":[89],"a":[90,190],">15%":[91],"decrease":[92],"FEV(1)":[94],"from":[95],"baseline":[96],"any":[98],"assessment":[99],"up":[100],"24":[102],"hours":[103],"post-baseline":[104],"was":[105],"not":[106],"statistically":[107],"significantly":[108],"different":[109],"between":[110],"groups":[116],"stratum.":[122],"Dyspnea,":[123],"most":[125],"frequent":[126],"respiratory":[127],"adverse":[128],"event,":[129],"occurred":[130],"higher":[132],"incidence":[133],"(P":[134],"<":[135],".0001)":[136],"group":[140,144],"than":[141],"(10.7%":[148],"vs":[149,154],"1.1%)":[150],"(18.0%":[153],"2.6%)":[155],"strata.":[156],"No":[157],"experienced":[159],"severe":[160],"although":[162],"occurrence":[164],"such":[166,176],"reactions":[167],"adenosine":[169],"agonists":[171],"cannot":[172],"be":[173,185],"ruled":[174],"out,":[175],"that":[177],"caution":[178],"is":[179],"advised.":[180],"CONCLUSIONS:":[181],"This":[182],"information":[183],"helpful":[186],"selecting":[189],"pharmacologic":[191],"agent":[193],"MPI":[195],"COPD.":[201]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2095004792","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
